BMXMF
Price
$138.15
Change
-$2.10 (-1.50%)
Updated
Sep 5 closing price
Capitalization
15.93B
FONR
Price
$15.60
Change
-$0.05 (-0.32%)
Updated
Sep 5 closing price
Capitalization
98.22M
Interact to see
Advertisement

BMXMF vs FONR

Header iconBMXMF vs FONR Comparison
Open Charts BMXMF vs FONRBanner chart's image
Biomerieux 69 Marcy L'Etoile
Price$138.15
Change-$2.10 (-1.50%)
Volume$197
Capitalization15.93B
Fonar
Price$15.60
Change-$0.05 (-0.32%)
Volume$7.22K
Capitalization98.22M
BMXMF vs FONR Comparison Chart in %
Loading...
BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMXMF vs. FONR commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMXMF is a Hold and FONR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BMXMF: $138.15 vs. FONR: $15.60)
Brand notoriety: BMXMF and FONR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BMXMF: 100% vs. FONR: 35%
Market capitalization -- BMXMF: $15.93B vs. FONR: $98.22M
BMXMF [@Medical Specialties] is valued at $15.93B. FONR’s [@Medical Specialties] market capitalization is $98.22M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMXMF’s FA Score shows that 1 FA rating(s) are green whileFONR’s FA Score has 1 green FA rating(s).

  • BMXMF’s FA Score: 1 green, 4 red.
  • FONR’s FA Score: 1 green, 4 red.
According to our system of comparison, BMXMF is a better buy in the long-term than FONR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMXMF’s TA Score shows that 4 TA indicator(s) are bullish while FONR’s TA Score has 5 bullish TA indicator(s).

  • BMXMF’s TA Score: 4 bullish, 5 bearish.
  • FONR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, FONR is a better buy in the short-term than BMXMF.

Price Growth

BMXMF (@Medical Specialties) experienced а -1.50% price change this week, while FONR (@Medical Specialties) price change was -2.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMXMF($15.9B) has a higher market cap than FONR($98.2M). BMXMF has higher P/E ratio than FONR: BMXMF (37.38) vs FONR (12.48). BMXMF YTD gains are higher at: 30.093 vs. FONR (3.038). BMXMF has higher annual earnings (EBITDA): 910M vs. FONR (23.2M). BMXMF has more cash in the bank: 450M vs. FONR (54.4M). FONR has less debt than BMXMF: FONR (39.8M) vs BMXMF (491M). BMXMF has higher revenues than FONR: BMXMF (3.98B) vs FONR (103M).
BMXMFFONRBMXMF / FONR
Capitalization15.9B98.2M16,191%
EBITDA910M23.2M3,922%
Gain YTD30.0933.038990%
P/E Ratio37.3812.48299%
Revenue3.98B103M3,864%
Total Cash450M54.4M827%
Total Debt491M39.8M1,234%
FUNDAMENTALS RATINGS
BMXMF vs FONR: Fundamental Ratings
BMXMF
FONR
OUTLOOK RATING
1..100
864
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7085
PRICE GROWTH RATING
1..100
5254
P/E GROWTH RATING
1..100
2930
SEASONALITY SCORE
1..100
5016

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMXMF's Valuation (45) in the null industry is in the same range as FONR (52) in the Medical Specialties industry. This means that BMXMF’s stock grew similarly to FONR’s over the last 12 months.

BMXMF's Profit vs Risk Rating (100) in the null industry is in the same range as FONR (100) in the Medical Specialties industry. This means that BMXMF’s stock grew similarly to FONR’s over the last 12 months.

BMXMF's SMR Rating (70) in the null industry is in the same range as FONR (85) in the Medical Specialties industry. This means that BMXMF’s stock grew similarly to FONR’s over the last 12 months.

BMXMF's Price Growth Rating (52) in the null industry is in the same range as FONR (54) in the Medical Specialties industry. This means that BMXMF’s stock grew similarly to FONR’s over the last 12 months.

BMXMF's P/E Growth Rating (29) in the null industry is in the same range as FONR (30) in the Medical Specialties industry. This means that BMXMF’s stock grew similarly to FONR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMXMFFONR
RSI
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
55%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
61%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
54%
Declines
ODDS (%)
Bearish Trend 16 days ago
53%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCHI23.050.09
+0.39%
Schwab 5-10 Year Corp Bd ETF
FIDI24.410.09
+0.38%
Fidelity International High Div ETF
GSSC74.880.21
+0.28%
Goldman Sachs ActiveBeta® US SmCp Eq ETF
ABLD28.98N/A
+0.01%
Abacus FCF Real Assets Leaders ETF
NVBT35.55-0.04
-0.11%
AllianzIM U.S. Large Cp Buffer10 Nov ETF

BMXMF and

Correlation & Price change

A.I.dvisor tells us that BMXMF and SOAGY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMXMF and SOAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMXMF
1D Price
Change %
BMXMF100%
-1.50%
SOAGY - BMXMF
26%
Poorly correlated
+3.02%
FONR - BMXMF
24%
Poorly correlated
-0.32%
SRTOY - BMXMF
23%
Poorly correlated
N/A
SNN - BMXMF
22%
Poorly correlated
+1.20%
BIO - BMXMF
21%
Poorly correlated
+2.07%
More

FONR and

Correlation & Price change

A.I.dvisor tells us that FONR and AZTA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FONR and AZTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FONR
1D Price
Change %
FONR100%
-0.32%
AZTA - FONR
32%
Poorly correlated
+2.64%
IMDX - FONR
30%
Poorly correlated
+0.40%
AVHHL - FONR
30%
Poorly correlated
N/A
KIDS - FONR
27%
Poorly correlated
+0.97%
VREX - FONR
26%
Poorly correlated
-0.09%
More